Suppr超能文献

用于治疗肝硬化继发难治性腹水或静脉曲张出血的原发性经颈静脉肝内门体分流术。

Primary constrained TIPS for treating refractory ascites or variceal bleeding secondary to hepatic cirrhosis.

作者信息

Rabei R, Mathevosian S, Tasse J, Madassery S, Arslan B, Turba U, Ahmed O

机构信息

1 Chicago Medical School , Rosalind Franklin University , North Chicago, IL , USA.

2 Rush University Medical Center , Chicago, IL , USA.

出版信息

Br J Radiol. 2018 Feb;91(1083):20170409. doi: 10.1259/bjr.20170409. Epub 2017 Dec 15.

Abstract

OBJECTIVE

To report an initial experience using a primary constrained transjugular intrahepatic portosystemic shunt (TIPS) technique for treating cirrhotic patients with refractory ascites or variceal bleeding.

METHODS

All patients undergoing primary constrained (n = 9) and conventional (n = 18) TIPS between July 2014 and June 2016 were retrospectively reviewed. Preprocedure demographics, Child-Pugh, model for end-stage liver disease and technical variables were recorded. Outcomes measured included technical and clinical success, complications, 30-day mortality, as well as necessity for TIPS revision. Average (SD) and median follow-up was 237 (190) and 226 days.

RESULTS

All constrained and conventional TIPS were technically successful (100%). Clinical success as defined as a reduction or improvement in presenting symptoms was 88.9% (8/9) and 100% (18/18) in the constrained and conventional groups, respectively (p = 1). The average reduction in portosystemic gradient was lower in the constrained group, 6.1 mmHg compared with 10.6 mmHg in the conventional group (p = 0.73). The rate of hepatic encephalopathy following TIPS placement was higher in the conventional group [16.7% (3/18)] compared with 0% in the constrained group (p = 0.52). The percentage of patients requiring TIPS revision was lower in the constrained group, although the results were not significant (11.1 vs 22.2%, p = 0.63).

CONCLUSION

Primary constrained TIPS is a feasible modification to conventional TIPS with similar technical and clinical success rates. A trend towards a smaller reduction in the portosystemic gradient and need for revision was observed in the constrained group. Advances in knowledge: Primary constrained TIPS allows for greater stepwise control over shunt diameter and may represent an improved technique for patients at risk for hepatic encephalopathy.

摘要

目的

报告使用原发性限制性经颈静脉肝内门体分流术(TIPS)治疗肝硬化难治性腹水或静脉曲张出血患者的初步经验。

方法

回顾性分析2014年7月至2016年6月期间接受原发性限制性(n = 9)和传统(n = 18)TIPS治疗的所有患者。记录术前人口统计学、Child-Pugh评分、终末期肝病模型及技术变量。测量的结果包括技术和临床成功率、并发症、30天死亡率以及TIPS修正的必要性。平均(标准差)和中位随访时间分别为237(190)天和226天。

结果

所有限制性和传统TIPS在技术上均成功(100%)。以症状减轻或改善定义的临床成功率在限制性组和传统组分别为88.9%(8/9)和100%(18/18)(p = 1)。限制性组门体压力梯度的平均降低幅度较低,为6.1 mmHg,而传统组为10.6 mmHg(p = 0.73)。TIPS置入后传统组肝性脑病发生率[16.7%(3/18)]高于限制性组的0%(p = 约0.52)。限制性组需要TIPS修正的患者百分比更低,尽管结果无统计学意义(11.1%对22.2%,p = 0.63)。

结论

原发性限制性TIPS是对传统TIPS的一种可行改良,技术和临床成功率相似。在限制性组中观察到门体压力梯度降低幅度较小及修正需求的趋势。知识进展:原发性限制性TIPS允许对分流直径进行更大程度的逐步控制,可能是一种对有肝性脑病风险患者的改良技术。

相似文献

1
Primary constrained TIPS for treating refractory ascites or variceal bleeding secondary to hepatic cirrhosis.
Br J Radiol. 2018 Feb;91(1083):20170409. doi: 10.1259/bjr.20170409. Epub 2017 Dec 15.
2
Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.
AJR Am J Roentgenol. 2018 Feb;210(2):438-446. doi: 10.2214/AJR.17.18222. Epub 2017 Dec 20.
3
The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S344-51. doi: 10.1097/MCG.0b013e318157e500.
9
Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG.
Scand J Gastroenterol. 2016 Dec;51(12):1502-1506. doi: 10.1080/00365521.2016.1193218. Epub 2016 Jul 5.

引用本文的文献

1
The transjugular intrahepatic portosystemic shunt: Smaller stent diameters are required to optimize pressure response.
ILIVER. 2023 May 27;2(2):89-96. doi: 10.1016/j.iliver.2023.05.004. eCollection 2023 Jun.
2
IR management of portal hypertension complications.
Clin Liver Dis (Hoboken). 2023 Sep 2;22(2):75-79. doi: 10.1097/CLD.0000000000000077. eCollection 2023 Aug.
3
Transjugular Intrahepatic Portosystemic Shunt Placement: Entering the Era of Controlled Expansion.
Cardiovasc Intervent Radiol. 2023 Jun;46(6):823-824. doi: 10.1007/s00270-023-03450-w. Epub 2023 May 3.
4
How Controlled is the Expansion of VIATORR CX?
Cardiovasc Intervent Radiol. 2023 May;46(5):658-663. doi: 10.1007/s00270-023-03383-4. Epub 2023 Feb 24.
5
Hepatic Venous Pressure Gradient.
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):144-148. doi: 10.1002/cld.1031. eCollection 2021 Mar.
6
Current Management of Intestinal Stomas and Their Complications.
J Anus Rectum Colon. 2020 Jan 30;4(1):25-33. doi: 10.23922/jarc.2019-032. eCollection 2020.

本文引用的文献

4
5
The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips.
ISRN Hepatol. 2014 Mar 18;2014:762096. doi: 10.1155/2014/762096. eCollection 2014.
7
The Transjugular Intrahepatic Portosystemic Shunt: Technique and Instruments.
Tech Vasc Interv Radiol. 2016 Mar;19(1):2-9. doi: 10.1053/j.tvir.2016.01.001. Epub 2016 Jan 28.
8
Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunts.
J Vasc Interv Radiol. 2016 Jan;27(1):1-7. doi: 10.1016/j.jvir.2015.09.018. Epub 2015 Nov 21.
9
Transjugular intrahepatic portosystemic shunt complications: prevention and management.
Semin Intervent Radiol. 2015 Jun;32(2):123-32. doi: 10.1055/s-0035-1549376.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验